Nasdaq

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV) ...
KELOLAND News

Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Completion of a Trial Protocol to Study its Self Assembling Vaccine to Target Prostate Stem Cell Antigen

Vaccine was shown to induce immunity against Prostate Stem Cell Antigen (PSCA) previously Full protein targeting expands the Self-Assembling Vaccine (SAV) platform's potential targets NEW YORK, Nov.
Business Insider

Voltron Therapeutics, Inc. Announces Completion of First Small Animal Safety and Immunogenicity Study Assessing the Effect of Novel COVID-19 Vaccine, HaloVax™

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today the successful completion of its previously announced first small animal safety and immunogenicity study ...
Nasdaq

Voltron Therapeutics, Inc. Announces Positive Data from Animal Testing of Self-Assembling Vaccine in the Fight Against COVID-19

NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced positive data from its second set of preclinical animal testing of its HaloVax™ Self-Assembling Vaccine (SAV) ...